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It is well recognized that the Shiga-like toxins (Stxs) preferentially bind to Gb3 glycolipids and the cholera toxin (CT) and heat-labile
enterotoxin (LTp) bind to GM1 gangliosides. After binding to the cell surface, A-B bacterial enterotoxins have to be internalized by
endocytosis. The transport of the toxin–glycolipid complex has been documented in several manners but the actual mechanisms are yet to be
clarified. We applied a heterobifunctional cross-linker, sulfosuccinimidyl-2-( p-azidosalicylamido)-1,3V-dithiopropionate (SASD), to detect
the membrane proteins involved in the binding and the transport of A-B bacterial enterotoxins in cultured cells. Both Stx1 and Stx2 bound to
the detergent-insoluble microdomain (DIM) of Vero cells and Caco-2 cells, which were susceptible to the toxin, but neither was bound to
insusceptible CHO-K1 cells. Both CT and LTp bound to the DIM of Vero cells, Caco-2 cells, and CHO-K1 cells. In a cross-linking
experiment, Stx1 cross-linked only with a 27-kDa molecule, while Stx2, which was more potently toxic than Stx1, cross-linked with 27- and
40-kDa molecules of Vero cells as well as of Caco-2 cells; moreover, no molecules were cross-linked with the insusceptible CHO-K1 cells.
LTp was cross-linked only to the 27-kDa molecule of these three cell types but the CT, which was more toxic than LTp, was also cross-linked
with 27- and 40-kDa molecules of Vero cells, Caco-2 cells, and CHO-K1 cells. The 27- and the 40-kDa molecules might play a role in the
endocytosis and retrograde transport of A-B bacterial enterotoxins.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Shiga-like toxin; Cholera toxin; Heat-labile enterotoxin; A-B enterotoxin; Raft; Receptor
1. Introduction Lipid rafts are rich in signal transduction molecules suchLipid microdomains, or lipid rafts, are dynamic regions
in plasma membranes. Lipid rafts are characterized as
detergent-insoluble, light in density, and rich in cholesterol;
they contain glycolipids and GPI-linked proteins that are
anchored in the membrane by glycosyl-phosphatidylinositol
lipids [1,2]. Lipid rafts appear to be responsible for diverse
functions such as polarized secretion, membrane transport,
and cell polarity, although their comprehensive function is
not yet well understood [2–4].0005-2736/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0005-2736(03)00130-5
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Hachioji, Tokyo, 192-0031, Japan.as receptor tyrosine kinases, mitogen-activated protein
(MAP) kinases, adenylyl cyclase, and lipid signaling inter-
mediates [1]. Although lipid rafts comprise only a small
percentage of the cell surface area, they are also known to
mediate the fission of plasma membranes and endocytosis
[5]. Hence, as regards pathogenic microbial agents, lipid
rafts are preferable targets for susceptible host cells. For
example, Gb3 glycolipid, a receptor for Stx1, is present in
detergent-insoluble microdomain (DIM) of ACHN cells and
is associated with Src family tyrosine kinase Yes [6]. GM1
ganglioside, a receptor for cholera toxin (CT), is present on
the entire surface but is concentrated in lipid rafts of
susceptible cells [5]. Lipid rafts have been shown to play
a role in the cytotoxicity of CT, a phenomenon observed in
the case in which CT activation was highly dependent on the
clustering of cholesterol within the microdomain on the
plasma membrane [7,8].ed.
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ichia coli (EHEC) and are associated with hemorrhagic
colitis and hemolytic uremic syndrome [9]. CT and LT are
responsible for massive watery diarrheas caused by the
infection with Vibrio cholerae and enterotoxigenic E. coli
(ETEC) [10]. These toxins are composed of two subunits, A
and B [9,10]. The A subunit of Stxs is the toxic molecule
whose RNA N-glycosidase activity leads to the inhibition of
protein synthesis in the target cell [11]. The A subunits of
CT and LT activate adenylyl cyclase by catalyzing ADP-
ribosylation of the heterotrimeric GTPase Gsa [12–14].
These A-B enterotoxins share some features in common: (i)
the A subunit is a toxic molecule which is surrounded with
five molecules of B subunit [9,10]; (ii) the pentameric B-
subunits recognize and bind to the receptor glycolipids on
the cell membrane [9,10]; and (iii) these enterotoxins enter
into susceptible cells by endocytosis followed by membrane
traffic transport through the Golgi cisternae to the endo-
plasmic reticulum (ER) [15–20].
Although the molecular structure and function of Stx1
and Stx2 are similar, their modes of binding and toxicities
have been reported to be somewhat different [21–24]. The
cytotoxicity of human renal endothelial cells was found to
be about 1000-fold more potent in Stx2 than Stx1 [25],
although Stx1 and Stx2 displayed indistinguishable RNA N-
glycosidase activity in a cell-free system [26]. Similarly,
although CT and LT share many features in common, they
are clearly different molecules, which are distinguishable by
their modes of binding to receptor molecules and in the
potency of their toxicities [27–30]. The receptor moieties of
these molecules are the same and their ultimate effects on
cell metabolism are also identical; possible explanations for
their differences as regards toxic potency are therefore of
great interest. We assumed here that the signal transduction
molecules in the cell membrane might control the magni-
tude of toxic activity in the cell. In this study, we demon-
strated that Stx1 bound to the 27-kDa molecule, and Stx2
bound to the 27- and 40-kDa molecules on the cell surface,
suggesting that Stx1 and Stx2 possess different modes of
binding to Gb3. Since the same results were obtained using
CT and LTp, these 27- and 40-kDa molecules are thought to
play a key role in the initiation of the signal transduction
that controls the magnitude of toxic effects on susceptible
cells.2. Materials and methods
2.1. Toxins and antibodies
Stx1 and polyclonal antibody for Stx1 were prepared as
described previously [31]. Stx2 and polyclonal antibody for
Stx2 were also prepared according to a previously described
method [32]. In addition, CT and LTp, and polyclonal
antibodies for CT and LTp, were prepared as previously
described [33].A hybridoma cell line secreting antibodies to Stx1 or
Stx2 was isolated from the fusion of P3U1 mouse mye-
loma cells with spleen cells from BALB/c mice immu-
nized with Stx1 mutant (Q167D) toxoid or Stx2 mutant
(Q167D) toxoid. Toxoid used in immunization was pro-
duced by formaldehyde treatment of purified Stx1 mutant
or Stx2 mutant. The culture supernatant of hybridoma
cells was screened first by ELISA and then by cytotoxin
neutralization assay. The subisotypes of the monoclonal
antibody (mAb) were determined with a mouse mAb
isotyping kit (Amersham Pharmacia Biotech UK, Ltd.,
Buckinghamshire, England). The subisotypes of the mouse
anti-Stx1B mAb VT1-34, anti-Stx2A mAb VT2-32, and
anti-Stx2B mAb VT2-22 were IgG2b, IgG2a, and IgG2a,
respectively.
Stx1 and Stx2 were cross-linked with disuccinimidyl
suberate (DSS) (Pierce Chemical Co., Rockford, IL) accord-
ing to the manufacturer’s instructions.
2.2. Cells
The African green monkey kidney-derived Vero cell line,
the Chinese hamster ovary-derived CHO-K1 cell line, and
the human colon-derived Caco-2 cell line were obtained
from Riken Cell Bank (RCB0001, RCB0285, and
RCB0988, respectively). Vero cells and CHO-K1 cells were
maintained in Eagle’s minimum essential medium (MEM,
Sigma, St. Louis, MO) supplemented with 10% fetal bovine
serum and 1% antibiotic antimycotic solution (Sigma).
Caco-2 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma) supplemented with 10%
fetal bovine serum and 1% antibiotic antimycotic solution
(Sigma). For the binding assay of toxins, cells in a 15-cm
culture dish were kept at 4 jC for 30 min and were then
incubated with various toxins (Stx1 and Stx2 at 0.3 Ag/10
ml, CT and LTp at 30 Ag/10 ml) in a culture medium
containing 10% fetal bovine serum maintained at 4 jC for
30 min. Cells were then washed in ice-cold PBS(+) twice to
remove unbound toxins.
2.3. Assay of cytotoxicity
The cytotoxicity of Stx1 and Stx2 to various cell lines
was examined as described previously [31].
2.4. CHO cell assay
The ability of CT and LTp to elongate CHO-K1 cells was
examined by a previously described method [34].
2.5. DIM preparation
Cells in a 15-cm culture dish were lysed and homogen-
ized using a Teflon glass homogenizer in 0.8 ml of MES-
buffered saline (25 mM MES, 0.15 M NaCl (pH 6.5))
containing 1% Triton X-100 and protease inhibitor cocktail
Fig. 1. Sensitivities of various cell lines against Stx1 and Stx2. Three cell
lines were grown on 96-well plates in duplicate. The cells were incubated in
the presence of increasing concentrations of Stx1 or Stx2. Cytotoxicity was
measured after 48 h using cell counting kit-8 (Dojindo Laboratories,
Kumamoto, Japan).
Fig. 2. Cell elongation effect of CT and LTp on CHO-K1 cells. CHO-K1
cells were grown on a 16-well glass chamber slide. The cells were
incubated in the presence of increasing concentrations of CT or LTp.
Cultures were examined for morphological changes after 18 h.
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homogenate was adjusted to 40% sucrose (w/v), overlaid
with 2.4 ml of 36% sucrose and 1.2 ml of 5% sucrose in
MES-buffered saline (pH 6.5), and was centrifuged at
45,000 rpm (250,000 g) for 18 h at 4 jC in a Beckman
SW55Ti rotor. Samples were then fractionated from the top
(0.4 ml each, fractions 1 to 11). The pellet was suspended in
0.4 ml of MES-buffered saline (pH 6.5), sonicated, and
designated as fraction 12.
2.6. Labeling of toxins
Iodination of sulfosuccinimidyl-2-( p-azidosalicylamido)-
1,3V-dithiopropionate (SASD) (Pierce) with Iodogen (Pierce)
and conjugation of 125I-SASD with Stx1, Stx2, CT, or LTp
was carried out according to the procedure supplied by
Pierce. The reagent, 3 mg of SASD, was dissolved in 100
Al of dimethyl sulfoxide in a glass tube in the dark, and 10 Al
of the solution was added to 90 Al of 0.1M sodium phosphate,
pH 7.4. The Iodogen film was prepared by dissolving 1 mg of
solid Iodogen in 100 Al of chloroform and then evaporating
the chloroform under N2. Next, the SASD solution (100 Al)
and 500 ACi 125I-Na (0.1 mCi/ml) (NEN Life Science
Products, MA, USA) were quickly added to the glass tube
coated with Iodogen film. The reaction was allowed to
proceed for exactly 30 s before it was stopped by removal
of the solution from the Iodogen film and addition of 18.5
nmol of KI in 10 Al of 0.1 M sodium phosphate, pH 7.4. The
reaction mixture was divided into four equal portions. Then,
the 125I-SASD-Stx1, -Stx2, -CT, or -LTp was prepared by
incubating 5 Ag of Stx1, Stx2, CT, or LTp in 75 Al of 0.1 M
sodium borate buffer, pH 8.4, with the 125I-SASD for 30 minat room temperature. The 125I-SASD-Stx1 ,-Stx2, -CT, or -
LTp was removed from the free radioactivity by passing the
reaction mixtures individually through a 1.3-ml Sephadex
G50 column equilibrated with PBS buffer. Fractions of 5
drops were collected, and the radioactivity of 1-Al aliquots
was monitored using gamma counter. The first eluting radio-
active fractions containing the 125I-SASD-Stx1, -Stx2, -CT,
or -LTp were used for the cross-linking experiments.
2.7. Binding and covalent cross-linking of toxin to cells
Vero cells, Caco-2 cells, or CHO-K1 cells were grown to
confluence on sterile six-well tissue culture plates and were
placed on ice for 30 min. The monolayers were washed
twice with EMEM (without sodium bicarbonate) (Nissui
Pharmaceutical CO., Ltd., Tokyo, Japan) supplemented with
20 mM HEPES buffer (EMEM-H: pH 7.4) and twice with
EMEM-H supplemented with 1.0 mg/ml BSA (EMEM-
BSA). 125I-SASD-Stx1, -Stx2, -CT, or -LTp in 500-Al
EMEM-BSA was added to the monolayers, which were
incubated for 3 h on a rocking platform at 4 jC in the dark.
Unbound Stx1, Stx2, CT, or LTp were removed and the
monolayers were washed once with EMEM-BSA and three
times with EMEM-H. The monolayers were photolyzed
with short-wavelength UV light (Spectroline, short-wave
hand lamp, 450–1250 AW/cm2 at 254 nm at 15 cm) for 15
min and each well was washed once with EMEM-H. One
milliliter of sucrose detachment buffer (pH 7.6; 8.5 g
sucrose/100 ml, 10 mM Tris, 1.0 mM EDTA, 2.0 mM
PMSF) was added to each well. The cells were detached
using a cell scraper and centrifuged at 12,000 g for 15 min
at 4 jC. SDS-PAGE sample buffer was added to the cell
pellets with vortexing and incubated at 100 jC for 5 min.
The cross-linked molecules were analyzed by SDS-PAGE
Fig. 3. The distribution of Stx1 and Stx2 in the sucrose density gradient fraction. Various Stx1- or Stx2-bound cell lines were treated with 1% Triton X-100,
homogenized, subjected to sucrose density gradient centrifugation, and fractionated from the top (fraction 1) to a pellet (fraction 12). All of the proteins in each
fraction were separated by SDS-PAGE, transferred to a PVDF membrane, and detected using anti-Stx1 or -Stx2 polyclonal antibodies with an enhanced
chemiluminescence system (ECL, Amersham Pharmacia Biotech).
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stained with Coomassie brilliant blue R250 and radiola-
belled molecule bands were detected by a Bio-imaging
analyzer (Fuji Film, Tokyo, Japan).3. Results
3.1. Difference in the sensitivity of cultured cells to A-B
enterotoxins
The Stx1 and Stx2 were cytotoxic to Vero cells and
Caco-2 cells in a dose-dependent manner (Fig. 1). The CD50
of Stx2 was 6 pg/ml while that of Stx1 was 400 pg/ml (Fig.
1), thus indicating that Stx2 was 70-fold more potent to Vero
cells than Stx1. The CD50 of Stx2 on Caco-2 cells was 10
Ag/ml and that of Stx1 was almost the same as that of Stx2.
Both Stx1 and Stx2 did not exert any effect on CHO-K1
cells that lacked the Gb3 receptor on the cell surface
[35,36].
The toxicity of CT and LTp was examined by the potency
of the cell elongation activity on CHO-K1 cells. The
elongation concentrations required to produce an elongation
effect in 50% of CHO cells in a well were as follows: CT, 60
ng/ml; LTp, 1000 ng/ml (Fig. 2). CT had a 20-fold more
potent effect than LTp on CHO-K1 cells. These results wereFig. 4. The distribution of CT and LTp in the sucrose density gradient fraction.
homogenised, subjected to sucrose density gradient centrifugation, and fractionated
fraction were separated by SDS-PAGE, transferred to PVDF membranes, and
chemiluminescence system (ECL, Amersham Pharmacia Biotech UK).found to be consistent with those of previous studies
[29,30].
3.2. A-B enterotoxins bound to the DIM
When the cells were treated with Stx1 and Stx2 followed
by sucrose density gradient centrifugation, the toxins were
found to be associated with the DIM. The toxin-associated
DIMs were detectable in both Caco-2 cells and Vero cells,
but not in CHO-K1 cells (Fig. 3). Even when the cells were
treated with the larger amount of Stx1 and Stx2 (6 Ag each,
i.e., 50-fold increase), the toxin-associated DIMs were not
detectable in the CHO-K1 cells (data not shown).
CT and LTp were also bound to the DIM of Vero cells
and Caco-2 cells, as is clearly shown in Fig. 4. In contrast
with Stx1 and Stx2, these toxins also bound to the DIM of
CHO-K1 cells (Fig. 4).
3.3. Identification of Stxs-binding molecules in the DIM by
photoaffinity cross-linking
To detect the toxin-binding molecules in the cell mem-
brane, we used 125I-SASD-Stx1 or 125I-SASD-Stx2 to cross-
link the toxins with the receptor-associated membrane
molecules. General structure of the SASD cross-linker is
shown in Fig. 5.Various CT- or LTp-bound cell lines were treated with 1% Triton X-100,
from the top (fraction 1) to a pellet (fraction 12). All of the proteins in each
detected using anti CT or LTp polyclonal antibodies with an enhanced
Fig. 5. General structure of the photoaffinity cross-linker SASD. There are two vital parts of the SASD: (1) sulfo-NHS ester and (2) hydroxyphenyl azide. The
hydroxyl group of the phenyl ring is iodinated and then Sulfo-NHS ester is reacted with amino group of toxins. When 125I-SASD-toxins are incubated with the
cells in the dark, they interacted with the specific glycolipids on the cell surface and form stable noncovalent complexes. After UV illumination, the azide group
becomes a highly reactive nitrene group which nonselecively forms a covalent bond with adjacent molecules. SASD is cleaved by reducing reagent (e.g. 2-
mercaptoethanol), resulting in cross-linking of the radioactive label with a single target molecule.
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SASD-Stx2, with or without an excess of nonlabelled Stx1
or Stx2, and the cells were subjected to SDS-PAGE under
reducing conditions. Stx1 was detectable at two bands (27
and 31 kDa) and Stx2 was found at three bands (27, 32, and
40 kDa) in the Vero cells (Fig. 6B). Among these radio-
labelled bands, two major bands (31 kDa in Stx1 and 32
kDa in Stx2) were the A subunits of Stxs, since these bands
were also detected by autoradiography of labelled holotoxin
alone (Fig. 6A).
To prove that these 27- and 40-kDa molecules did not
consist of the A subunits and/or the B subunits of Stxs, Vero
cells were incubated with SASD-Stx1 or SASD-Stx2, and
the cells were subjected to SDS-PAGE under reducing
conditions. The A subunits of Stxs were detected at only
one band (31 kDa in Stx1 and 32 kDa in Stx2) by
immunoblot using anti-Stx1 polyclonal antibody and anti-Fig. 6. Autoradiography of cross-linking with 125I-SASD-Stx1 and 125I-SASD-Stx
UV-treated 125I-SASD-Stx1 and 125I-SASD-Stx2 alone. Vero cells (B), butyrate tre
3 and lanes 4–6) received the same initial concentration (about 1 Ag each) of 125I-S
5 and 10 Ag of unlabelled Stx1. Lanes 5 and 6 represent wells that received 5 and 1
butyrate for 4 days, except in the case of lanes 1 and 5. All monolayer wells (lan
each) of 125I-SASD-Stx1 and 125I-SASD-Stx2. Lanes 3 and 4 represent wells that
received 5 and 10 Ag of unlabelled Stx2. Arrows indicate the covalent cross-linkin
molecules.Stx2A mAb VT2-32 (Fig. 7A and C). The oligomers of B
subunits of Stxs were not detectable by immunoblot using
anti-Stx1B mAb VT1-34 and anti-Stx2B mAb VT2-22 (Fig.
7B and D). Both mAbs recognized only the oligomeric B
subunits of Stxs (Fig. 7B and D). These results indicated
that the 27- and the 40-kDa molecules were eukaryotic
membrane molecules.
These bands were diminished in the presence of an
excess of nonradioactive Stx1 or Stx2 (about 5-fold and
10-fold) in a dose-dependent manner. The results indicated
that the Stx1 specifically interacted with the 27-kDa mole-
cule, and Stx2 specifically interacted with the 27- and 40-
kDa molecules.
When Caco-2 cells were treated with 125I-SASD-Stx1 or
125I-SASD-Stx2 in the same manner as with Vero cells, the
resulting pattern of radiolabelled bands was similar to that
observed with the Vero cells (Fig. 6C). The intensity of2. (A) Lanes 1 and 2 were CBB-stained Stx1 and Stx2. Lanes 3 and 4 were
ated Caco-2 cells (C), and CHO-K1 cells (D). (B and D) All wells (lanes 1–
ASD-Stx1 and 125I-SASD-Stx2. Lanes 2 and 3 represent wells that received
0 Ag of unlabelled Stx2. (C) Confluent Caco-2 cells were treated with 2 mM
es 1–4 and lanes 5–8) received the same initial concentration (about 1 Ag
received 5 and 10 Ag of unlabelled Stx1. Lanes 7 and 8 represent wells that
g of 125I-SASD-Stx1 or 125I-SASD-Stx2 with various denatured cell surface
Fig. 7. Immunodetection of cross-linking with SASD-Stx1 and SASD-Stx2. (A) Lanes 1, 2, and 3 were Stx1, SASD-Stx1 cross-linked Vero cell lysate, and
Vero cell lysate, respectively. (B) Lanes 1, 2, 3, and 4 were DSS cross-linked Stx1, Stx1, SASD-Stx1 cross-linked Vero cell lysate, and Vero cell lysate,
respectively. (C) Lanes 1, 2, and 3 were Stx2, SASD-Stx2 cross-linked Vero cell lysate, and Vero cell lysate, respectively. (D) Lanes 1, 2, 3, and 4 were DSS
cross-linked Stx2, Stx2, SASD-Stx2 cross-linked Vero cell lysate, and Vero cell lysate, respectively. The blot was probed with anti-Stx1 polyclonal antibody
(A), anti-Stx1B mAb VT1-34 (B), anti-Stx2A mAb VT2-32 (C), or anti-Stx2B m
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mM butyrate for 4 days, and the intensity decreased in the
presence of excess Stx1 or Stx2 (about 5-fold and 10-fold)
in a dose-dependent manner (Fig. 6C).
When CHO-K1 cells were examined in the same manner
as were the Vero cells and Caco-2 cells, no radiolabelled
bands were observed (Fig. 6D). Signal bands appearing at
around 30 kDa were nonspecific, as the excess nonlabelled
toxin did not decrease the intensity of the signal. This result
suggested that both the 27- and 40-kDa molecules were
closely associated with the receptor that was located in the
DIM of Vero cells and Caco-2 cells.Fig. 8. Autoradiography of cross-linking with 125I-SASD-CT and 125I-SASD-LTp.
treated 125I-SASD-CT and 125I-SASD-LTp alone. Vero cells (B), butyrate treated C
lanes 4–6) received the same initial concentration (about 1 Ag each) of 125I-SASD
10 Ag of unlabelled CT. Lanes 5 and 6 represent wells that received 5 and 10 Ag of
for 4 days, except in the case of lanes 1 and 5. All monolayer wells (lanes 1–4 and
SASD-CT and 125I-SASD-LTp. Lanes 3 and 4 represent wells that received 5 and 1
Ag of unlabelled LTp. Arrows indicate the covalent cross-linking of 125I-SASD-C3.4. Identification of CT- and LTp-binding molecules in the
DIM by photoaffinity cross-linking
The binding of CT and LTp to the cultured cells was
examined in the same manner as that used for the Stx1 and
Stx2 observations. SDS-PAGE and autoradiograph analysis
revealed that CT was bound to 27-, 31-, and 40-kDa
molecules; LTp was bound to 27- and 29-kDa molecules
on the Vero cell surface (Fig. 8B). Among these radio-
labelled bands, two major bands (31 kDa in CT and 29 kDa
in LTp) were the A subunits of CT and LTp, respectively,
since these bands were also detected by autoradiography of
Ab VT 2-22 (D).(A) Lanes 1 and 2 were CBB-stained CT and LTp. Lanes 3 and 4 were UV-
aco-2 cells (C), and CHO-K1 cells (D). (B and D) All wells (lanes 1–3 and
-CT and 125I-SASD-LTp. Lanes 2 and 3 represent wells that received 5 and
unlabelled LTp. (C) Confluent Caco-2 cells were treated with 2 mM butyrate
lanes 5–8) received the same initial concentration (about 1 Ag each) of 125I-
0 Ag of unlabelled CT. Lanes 7 and 8 represent wells that received 5 and 10
T or 125I-SASD-LTp with various denatured cell surface molecules.
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CT or LTp (about 5-fold and 10-fold), radiolabelled 27- and
40-kDa bands, or a 27-kDa band was diminished in dose-
dependent manner, showing that binding was specific in the
case of each toxin (Fig. 8B). These patterns were similar to
those observed with Stx1 and Stx2.
In the case of Caco-2 cells, the pattern of radiolabelled
bands was similar to that demonstrated with the Vero cells
(Fig. 8C). The intensity of these radiolabelled bands was
also increased by treatment with 2 mM butyrate for 4 days
and this intensity decreased in the presence of excess CT or
LTp (about 5-fold and 10-fold) in a dose-dependent manner
(Fig. 8C).
When CHO-K1 cells were examined in the same manner,
CT bound to 27- and 40-kDa molecules, and LTp bound to
the 27-kDa molecule (Fig. 8D).4. Discussion
Vero cells are known to be highly sensitive to Stx1 and
Stx2, and Caco-2 cells were moderately susceptible to cyto-
toxic effects, whereas CHO-K1 cells are known to be resist-
ant to these toxins due to the lack of Gb3 on the cell surface
[35,36]. Confocal laser scanning microscopy and immuno-
fluorescence analyses revealed that the labelling intensity
was homogeneous in confluent Vero cells, and confluent
Caco-2 cells showed some heterogeneity from cell to cell in
the same population. About 50–70% of confluent Caco-2
cells was not distinguishable from the background. Confluent
CHO K-1 cells were found to be not labelled (T. Shimizu,
unpublished data). Therefore, the reason for these differences
in sensitivity may be due to the differential binding of toxins
to the cell surfaces. However, recombinant CHO-K1 cells, to
which Gb3 synthase genes were introduced, have been
shown to be susceptible to the toxins [37]; however, the
introduction of Gb3 molecules alone into the cell membrane
using liposomes did not induce susceptibility [35]. These
findings suggest that the Gb3 molecule alone is not sufficient
to confer susceptibility; some other factors, most probably
receptor-associated proteins which transfer or modulate the
toxic signal, are most likely needed to induce cytotoxicity.
Using radioiodinatable, cleavable, and photoreactive het-
erobifunctional cross-linker SASD, we demonstrated that A-
B bacterial enterotoxins bind to certain membrane proteins
that are located near receptor molecules. Enterotoxins, i.e.,
Stx1 and LTp, which have a moderate effect on susceptible
cultured cells, were in close proximity with a 27-kDa mole-
cule. Stx2 and CT, which are severely cytotoxic to cultured
cells, were in close proximity to 27- and 40-kDa molecules in
the susceptible cells. Since the length of the spacer arm of this
cross-linker was 18.9 A˚, the distance between the toxin
molecules and the binding proteins may be within 18.9 A˚.
Devenish et al. [38] utilized a simple bifunctional cross-
linker, disuccinimidyl suberate (DSS), and demonstrated
that Stx1 and Stx2 caused an interaction with a number ofproteins on the cell surface. However, the identity of the
multiple proteins observed in the case of both Stxs holotox-
ins could not be determined with absolute certainty in that
study because the protein-binding site may have cross-
linked different combinations of A and B subunits in various
patterns. On the other hand, the heterobifunctional cross-
linker SASD had the ability to specifically transfer the
radioactive label from the toxins to target molecules.
When 125I-SASD-Stx1 or 125I-SASD-Stx2 was mixed
with Caco-2 cells in the presence of butyrate, the intensities
of the 27- and 40-kDa radiolabelled bands were enhanced.
This result was consistent with the finding that the treatment
of Caco-2 cells with butyrate increased the amount of Gb3
on the cell surface [39]. The increasing of the intensities of
the 27- and 40-kDa radiolabelled bands was also the case for
binding observed between CT and LTp to Caco-2 cells (Fig.
8C). It is suggested that butyrate also up-regulated the
expression of GM1. Butyrate acts as a transcriptional
regulator of differentiation genes in many cell types [40–
42] and it has been shown to possess the potential to alter
the expression of both glycolipids [43] and glycoproteins
[40] on certain cell surfaces.
Katagiri et al. [6] used an anti-Gb3 monoclonal antibody
and immunoprecipitated a protein with an apparent molec-
ular mass of 27.2 kDa from the DIM of biotinylated ACHN
cells. The 27.2-kDa protein may be identical with the 27-
kDa molecule, which cross-linked with the Stx1 and Stx2 in
this study. Nakajima et al. [24] analyzed the binding affinity
of Stx1 and Stx2 to a sensor chip by surface plasmon
resonance and found that the association and dissociation
rate constants of Stx1 were larger than those of Stx2.
Miyake et al. [44] showed that Stx1 completely bound P1
antigenic ovomucoid glycoprotein of pigeon egg white,
whereas Stx2 did not.
Similarly, both CT and LTp were shown to bind to GM1,
but CT was restricted in that it was shown to bind only to
ganglioside GM1; in comparison, LT demonstrated a more
flexible mode of binding [28,45,46]. The abovementioned
studies and our data have shown clearly that the toxins
examined in this study bind to receptor glycolipids and that
the receptor-associated proteins play various roles in affect-
ing the magnitude of cytotoxicity. According to Hurley et al.
[47], Stx1 and Stx2 translocated across the Caco-2 cell
surface in a different manner. Apart from the 27-kDa
molecule, the 40-kDa molecule may be one of the determi-
nants of toxic signal transduction and/or endocytosis.
To account for the roles played by these molecules, their
biochemical properties should be characterized in detail. We
are currently focusing on such identification of these mol-
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